检索结果 - Stephanie Roberson
- Showing 1 - 2 results of 2
-
1
LY2439821, a humanized anti–interleukin‐17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double‐blind, placebo‐controlled, proo... 由 Mark C. Genovese, Filip Van den Bosch, Stephanie Roberson, S. Bojin, Ilaria Biagini, P. F. J. Ryan, J Sloan-Lancaster
出版 2010Artigo -
2
Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell... 由 Ravi Salgia, R Weaver, Michael McCleod, John R. Stille, S. Betty Yan, Stephanie Roberson, John Polzer, Amy Flynt, Eyas Raddad, Victoria L. Peek, Sameera R. Wijayawardana, Suzane L. Um, Steve Gross, Mark C. Connelly, Carrie Morano, Madeline Repollet, Renouard Sanders, Kurt Baeten, David D’Haese, David R. Spigel
出版 2017Artigo
相关主题
Internal medicine
Medicine
Adverse effect
Alternative medicine
Biochemistry
Biology
Biomarker
CXCR4
Cancer
Chemokine
Circulating tumor cell
Clinical endpoint
Gastroenterology
Lung cancer
Metastasis
Oncology
Pathology
Pharmacodynamics
Pharmacokinetics
Pharmacology
Placebo
Predictive marker
Randomized controlled trial
Receptor
Rheumatoid arthritis
Rheumatology
Tolerability